ÂÜÀòÂÒÂ×

David has spent most of his career working in Japan with Astellas and the predecessor company, Fujisawa. He is a senior-level leader and drug hunter with extensive expertise in infectious diseases and oncology, project management and has a track record of delivering quality, differentiated development candidates to the pipeline and market. In recent years, he has developed extensive management and leadership experience within Astellas with a focus on scientific excellence, effective global cross-functional interactions, leadership, responsibility, productivity, mentorship and influence.

David has extensive experience working with internal and external research programs, divisional governance, decision-making and reporting processes and interactions with domestic or overseas affiliates and partners, including CROs to help drive creation of innovative product candidates. David received his Ph.D. degree in Synthetic Organic Chemistry from Newcastle University in the UK and carried out post-doctoral research at Stanford University in the laboratory of Professor Barry M. Trost.